USTEKINUMAB-STBA

USTEKINUMAB-STBA was reported 371 times

USTEKINUMAB-STBA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VIRAL EPIGLOTTITIS 1 0.3333
1 HARVEY-BRADSHAW INDEX DECREASED 1 0.1667
2 VIRAL OESOPHAGITIS 1 0.0526
3 FAILED BACK SURGERY SYNDROME 1 0.0455
4 ULCERATIVE DUODENITIS 1 0.0244
5 BOWEL OBSTRUCTION SURGERY 1 0.0182
6 UROSTOMY 2 0.0168
7 UNADJUSTED DOSE ADMINISTERED 1 0.0147
8 SUSPECTED OFF LABEL USE 45 0.0100
9 SEXUAL ACTIVITY INCREASED 1 0.0084
10 SALIVARY DUCT OBSTRUCTION 1 0.0072
11 HARVEY-BRADSHAW INDEX INCREASED 2 0.0067
12 SALIVARY HYPOSECRETION 1 0.0062
13 INCISION SITE HAEMATOMA 1 0.0043
14 ILEOCAECAL RESECTION 1 0.0029
15 PRODUCT DOSE CONFUSION 1 0.0028
16 NASAL SEPTAL OPERATION 1 0.0028
17 SCROTAL ABSCESS 1 0.0026
18 LOSS OF THERAPEUTIC RESPONSE 8 0.0025
19 FAECAL CALPROTECTIN ABNORMAL 1 0.0024
20 BURSITIS INFECTIVE 1 0.0018
21 TREATMENT DELAYED 3 0.0017
22 SMALL INTESTINAL RESECTION 2 0.0017
23 EYE LASER SURGERY 1 0.0017
24 PROCTITIS ULCERATIVE 1 0.0017
25 DELIVERY 1 0.0015
26 WISDOM TEETH REMOVAL 2 0.0015
27 IMMUNISATION REACTION 1 0.0014
28 PALLIATIVE CARE 2 0.0013
29 TUMOUR EXCISION 1 0.0012
30 DEVICE LOOSENING 1 0.0012
31 STEROID DEPENDENCE 1 0.0011
32 FIBROMA 1 0.0011
33 AMYLASE INCREASED 4 0.0011
34 PRODUCT LEAKAGE 6 0.0011
35 ILEAL ULCER 1 0.0010
36 INTENTIONAL DOSE OMISSION 28 0.0010
37 EXPOSURE VIA SKIN CONTACT 24 0.0009
38 THERAPEUTIC RESPONSE CHANGED 5 0.0008
39 ABDOMINAL OPERATION 1 0.0008
40 LIP INJURY 1 0.0008
41 NEEDLE ISSUE 21 0.0007
42 ORAL DISORDER 5 0.0007
43 SYMPTOM RECURRENCE 4 0.0007
44 GASTROINTESTINAL INFLAMMATION 5 0.0006
45 PHARYNGEAL PARAESTHESIA 1 0.0006
46 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 2 0.0006
47 IMPRISONMENT 1 0.0006
48 SKIN HYPOPIGMENTATION 1 0.0006
49 ILEAL STENOSIS 1 0.0006
50 INTENTIONAL PRODUCT USE ISSUE 49 0.0006
51 ANAL ABSCESS 3 0.0006
52 DENTAL CARE 1 0.0005
53 LYMPH NODE PAIN 1 0.0005
54 PNEUMONIA FUNGAL 2 0.0005
55 SPINAL FUSION SURGERY 2 0.0005
56 EYE CONTUSION 1 0.0005
57 AMYOTROPHIC LATERAL SCLEROSIS 1 0.0005
58 PERIARTHRITIS 1 0.0004
59 BRAIN OPERATION 1 0.0004
60 DRUG DOSE OMISSION BY DEVICE 34 0.0004
61 PATELLA FRACTURE 1 0.0004
62 COLITIS MICROSCOPIC 2 0.0004
63 MUCOUS STOOLS 2 0.0004
64 ILEOSTOMY 1 0.0004
65 URINE OUTPUT INCREASED 1 0.0004
66 FOOD POISONING 2 0.0004
67 INTESTINAL RESECTION 2 0.0004
68 SERUM SICKNESS 1 0.0004
69 THERAPEUTIC RESPONSE DELAYED 1 0.0004
70 PROCTITIS 1 0.0004
71 CATARACT OPERATION 2 0.0003
72 IRITIS 1 0.0003
73 FAECAL CALPROTECTIN INCREASED 1 0.0003
74 POLYMYALGIA RHEUMATICA 1 0.0003
75 THERAPY CHANGE 3 0.0003
76 PRODUCT PREPARATION ISSUE 2 0.0003
77 SKIN INJURY 1 0.0003
78 DEVICE MALFUNCTION 19 0.0003
79 PRODUCT STORAGE ISSUE 1 0.0003
80 DEVICE PHYSICAL PROPERTY ISSUE 2 0.0003
81 ENURESIS 1 0.0002
82 INTESTINAL STENOSIS 1 0.0002
83 ABSCESS LIMB 1 0.0002
84 LUNG NEOPLASM 1 0.0002
85 PURULENT DISCHARGE 1 0.0002
86 ACCIDENTAL EXPOSURE TO PRODUCT 24 0.0002
87 CARDIAC OPERATION 2 0.0002
88 FAECES DISCOLOURED 5 0.0002
89 WHEELCHAIR USER 1 0.0002
90 BRAIN NEOPLASM MALIGNANT 1 0.0002
91 IRON DEFICIENCY 1 0.0002
92 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
93 SKIN TIGHTNESS 1 0.0002
94 INTESTINAL OBSTRUCTION 8 0.0002
95 SLEEP APNOEA SYNDROME 4 0.0002
96 SUBCUTANEOUS ABSCESS 1 0.0002
97 DEVICE LEAKAGE 9 0.0002
98 INFLAMMATORY MARKER INCREASED 1 0.0002
99 THERAPY INTERRUPTED 14 0.0002
100 DRUG DELIVERY SYSTEM MALFUNCTION 1 0.0002
101 PERIPHERAL VASCULAR DISORDER 1 0.0002
102 ANAL FISSURE 1 0.0002
103 GASTROINTESTINAL PAIN 2 0.0002
104 DRUG LEVEL BELOW THERAPEUTIC 1 0.0002
105 DEMENTIA 5 0.0002
106 COLECTOMY 1 0.0002
107 PERIORBITAL SWELLING 1 0.0002
108 SMALL INTESTINAL OBSTRUCTION 2 0.0002
109 SPINAL OPERATION 2 0.0002
110 INFUSION SITE EXTRAVASATION 1 0.0002
111 COLITIS ULCERATIVE 7 0.0002
112 PRODUCT SUBSTITUTION ISSUE 9 0.0002
113 SURGERY 9 0.0002
114 FREQUENT BOWEL MOVEMENTS 4 0.0001
115 PRODUCT LABEL ISSUE 1 0.0001
116 LARGE INTESTINE POLYP 1 0.0001
117 HAND FRACTURE 1 0.0001
118 FEAR OF INJECTION 1 0.0001
119 FAECES SOFT 1 0.0001
120 SENSITIVE SKIN 1 0.0001
121 THERAPY PARTIAL RESPONDER 2 0.0001
122 BRAIN FOG 2 0.0001
123 BLOOD ALBUMIN DECREASED 1 0.0001
124 ABSCESS 2 0.0001
125 FIBROMYALGIA 3 0.0001
126 MENSTRUAL DISORDER 1 0.0001
127 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
128 ABDOMINAL PAIN LOWER 3 0.0001
129 PRODUCT CONTAINER ISSUE 1 0.0001
130 GRIP STRENGTH DECREASED 1 0.0001
131 FACIAL PAIN 1 0.0001
132 HIDRADENITIS 1 0.0001
133 RETINAL DETACHMENT 1 0.0001
134 HAEMATOCHEZIA 6 0.0001
135 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
136 SPUTUM DISCOLOURED 1 0.0001
137 PRODUCT PACKAGING ISSUE 1 0.0001
138 ORAL HERPES 2 0.0001
139 INFLAMMATORY BOWEL DISEASE 1 0.0001
140 HOSPICE CARE 1 0.0001
141 BLADDER DISORDER 1 0.0001
142 PRODUCT ADMINISTRATION ERROR 2 0.0001
143 DRUG LEVEL DECREASED 1 0.0001
144 EAR DISCOMFORT 1 0.0001
145 INFLAMMATION 5 0.0001
146 WEIGHT FLUCTUATION 1 0.0001
147 INJECTION SITE DISCOMFORT 1 0.0001
148 MOUTH ULCERATION 2 0.0001
149 JOINT DISLOCATION 1 0.0001
150 RENAL PAIN 1 0.0001
151 PULMONARY THROMBOSIS 1 0.0001
152 OESOPHAGITIS 1 0.0001
153 WOUND INFECTION 1 0.0001
154 MALNUTRITION 1 0.0001
155 EYE INFECTION 1 0.0001
156 PRODUCT AVAILABILITY ISSUE 2 0.0001
157 MICTURITION URGENCY 1 0.0001
158 NEPHROLITHIASIS 4 0.0001
159 BLOOD IRON DECREASED 1 0.0001
160 PSORIASIS 11 0.0001
161 POLYNEUROPATHY 1 0.0001
162 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 15 0.0001
163 BRONCHITIS 6 0.0001
164 PHARYNGITIS 1 0.0001
165 DEVICE DEPLOYMENT ISSUE 1 0.0001
166 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
167 ORAL CANDIDIASIS 1 0.0001
168 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
169 HUNGER 1 0.0001
170 MASS 1 0.0001
171 SKIN REACTION 1 0.0001
172 RECTAL HAEMORRHAGE 3 0.0001
173 CONDITION AGGRAVATED 21 0.0001
174 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
175 INSURANCE ISSUE 1 0.0001
176 HOSPITALISATION 10 0.0001
177 FEMUR FRACTURE 2 0.0001
178 BASAL CELL CARCINOMA 1 0.0001
179 MENINGIOMA 1 0.0001
180 INFECTION 9 0.0001
181 PRODUCT DOSE OMISSION ISSUE 18 0.0001
182 CHOLELITHIASIS 2 0.0001
183 PERICARDITIS 1 0.0001
184 THERAPY CESSATION 3 0.0001
185 SCAR 1 0.0001
186 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
187 MUSCULOSKELETAL DISCOMFORT 1 0.0001
188 DEVICE DEFECTIVE 1 0.0001
189 SYRINGE ISSUE 1 0.0001
190 LYMPHADENOPATHY 2 0.0001
191 THIRST 1 0.0001
192 DEVICE ISSUE 5 0.0001
193 RASH PRURITIC 3 0.0001
194 BLOOD GLUCOSE ABNORMAL 1 0.0001
195 CONJUNCTIVITIS 1 0.0001
196 FLATULENCE 3 0.0001
197 FOOT FRACTURE 1 0.0001
198 BLOOD URINE PRESENT 1 0.0001
199 LOWER LIMB FRACTURE 1 0.0001
200 ABDOMINAL PAIN 12 0.0001
201 HAEMORRHOIDS 1 0.0001
202 PRODUCT PHYSICAL ISSUE 1 0.0000
203 BODY TEMPERATURE INCREASED 1 0.0000
204 PRODUCT PREPARATION ERROR 1 0.0000
205 POLLAKIURIA 2 0.0000
206 ABDOMINAL DISCOMFORT 8 0.0000
207 KNEE ARTHROPLASTY 1 0.0000
208 EATING DISORDER 1 0.0000
209 IMPAIRED WORK ABILITY 1 0.0000
210 POOR QUALITY SLEEP 1 0.0000
211 SKIN CANCER 1 0.0000
212 PRODUCT PRESCRIBING ISSUE 1 0.0000
213 MELAENA 1 0.0000
214 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
215 RASH PAPULAR 1 0.0000
216 PANCREATITIS ACUTE 1 0.0000
217 OROPHARYNGEAL PAIN 4 0.0000
218 CHILLS 5 0.0000
219 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
220 PRESYNCOPE 1 0.0000
221 OFF LABEL USE 35 0.0000
222 COVID-19 7 0.0000
223 CELLULITIS 2 0.0000
224 SKIN ULCER 1 0.0000
225 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
226 DEAFNESS 1 0.0000
227 ARTHRITIS 3 0.0000
228 GASTRITIS 1 0.0000
229 THROAT TIGHTNESS 1 0.0000
230 LIMB INJURY 1 0.0000
231 TREATMENT NONCOMPLIANCE 2 0.0000
232 SKIN LESION 1 0.0000
233 INFLUENZA LIKE ILLNESS 3 0.0000
234 MENTAL STATUS CHANGES 1 0.0000
235 SEPSIS 4 0.0000
236 MYALGIA 6 0.0000
237 PANCREATIC CARCINOMA 1 0.0000
238 DYSSTASIA 1 0.0000
239 CATARACT 2 0.0000
240 ILL-DEFINED DISORDER 2 0.0000
241 DISCOMFORT 2 0.0000
242 FEELING HOT 2 0.0000
243 LIMB DISCOMFORT 1 0.0000
244 SWOLLEN TONGUE 1 0.0000
245 METABOLIC ACIDOSIS 1 0.0000
246 DEEP VEIN THROMBOSIS 2 0.0000
247 URINARY RETENTION 1 0.0000
248 NEOPLASM MALIGNANT 2 0.0000
249 CEREBROVASCULAR ACCIDENT 5 0.0000
250 DEVICE USE ERROR 1 0.0000
251 RASH MACULAR 1 0.0000
252 HEART RATE DECREASED 1 0.0000
253 UNDERDOSE 2 0.0000
254 NASOPHARYNGITIS 5 0.0000
255 DYSPNOEA EXERTIONAL 1 0.0000
256 COLITIS 1 0.0000
257 ACNE 2 0.0000
258 INCORRECT DOSE ADMINISTERED 6 0.0000
259 PARAESTHESIA 4 0.0000
260 ABORTION SPONTANEOUS 1 0.0000
261 CARDIAC FAILURE 2 0.0000
262 EXTRA DOSE ADMINISTERED 1 0.0000
263 PSORIATIC ARTHROPATHY 1 0.0000
264 DEVICE BREAKAGE 1 0.0000
265 BLINDNESS 1 0.0000
266 OSTEOPOROSIS 1 0.0000
267 CARDIAC ARREST 2 0.0000
268 TREATMENT FAILURE 2 0.0000
269 ARTHRALGIA 10 0.0000
270 URTICARIA 4 0.0000
271 DEATH 20 0.0000
272 BALANCE DISORDER 2 0.0000
273 MENTAL DISORDER 1 0.0000
274 INTENTIONAL PRODUCT MISUSE 2 0.0000
275 DEHYDRATION 3 0.0000
276 ADVERSE DRUG REACTION 2 0.0000
277 THERAPY NON-RESPONDER 1 0.0000
278 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
279 SKIN IRRITATION 1 0.0000
280 SKIN DISCOLOURATION 1 0.0000
281 COGNITIVE DISORDER 1 0.0000
282 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
283 PRODUCT USE ISSUE 4 0.0000
284 PAIN 13 0.0000
285 PRODUCTIVE COUGH 1 0.0000
286 PRURITUS 8 0.0000
287 DIARRHOEA 13 0.0000
288 FLUID RETENTION 1 0.0000
289 CHEST DISCOMFORT 2 0.0000
290 SINUSITIS 2 0.0000
291 PERIPHERAL SWELLING 3 0.0000
292 ABDOMINAL PAIN UPPER 4 0.0000
293 ILLNESS 2 0.0000
294 FATIGUE 15 0.0000
295 ABDOMINAL DISTENSION 2 0.0000
296 INFLUENZA 2 0.0000
297 COUGH 5 0.0000
298 BLISTER 1 0.0000
299 EYE PAIN 1 0.0000
300 MUSCULAR WEAKNESS 2 0.0000
301 URINARY TRACT INFECTION 3 0.0000
302 LETHARGY 1 0.0000
303 BACK PAIN 4 0.0000
304 NASAL CONGESTION 1 0.0000
305 DISEASE PROGRESSION 2 0.0000
306 JOINT SWELLING 2 0.0000
307 THERAPEUTIC RESPONSE DECREASED 1 0.0000
308 SUICIDE ATTEMPT 1 0.0000
309 OEDEMA PERIPHERAL 2 0.0000
310 INJECTION SITE ERYTHEMA 2 0.0000
311 MALAISE 7 0.0000
312 LOSS OF CONSCIOUSNESS 2 0.0000
313 RHINORRHOEA 1 0.0000
314 AMNESIA 1 0.0000
315 INFUSION RELATED REACTION 1 0.0000
316 DRY SKIN 2 0.0000
317 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
318 VISION BLURRED 2 0.0000
319 SLEEP DISORDER 1 0.0000
320 DYSPNOEA 8 0.0000
321 SKIN BURNING SENSATION 1 0.0000
322 OVERDOSE 3 0.0000
323 RASH 6 0.0000
324 UNEVALUABLE EVENT 1 0.0000
325 ACUTE KIDNEY INJURY 2 0.0000
326 INJECTION SITE PAIN 4 0.0000
327 CARDIAC FAILURE CONGESTIVE 1 0.0000
328 THROMBOSIS 1 0.0000
329 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
330 CONFUSIONAL STATE 2 0.0000
331 FALL 4 0.0000
332 COMPLETED SUICIDE 1 0.0000
333 SKIN EXFOLIATION 1 0.0000
334 PYREXIA 4 0.0000
335 MUSCULOSKELETAL STIFFNESS 1 0.0000
336 TACHYCARDIA 1 0.0000
337 HEADACHE 7 0.0000
338 GASTROINTESTINAL DISORDER 1 0.0000
339 SUICIDAL IDEATION 1 0.0000
340 CHEST PAIN 2 0.0000
341 HYPERSENSITIVITY 2 0.0000
342 WEIGHT DECREASED 3 0.0000
343 BREAST CANCER 1 0.0000
344 SWELLING 1 0.0000
345 ASTHENIA 4 0.0000
346 GAIT DISTURBANCE 2 0.0000
347 CONTUSION 1 0.0000
348 DYSPEPSIA 1 0.0000
349 SOMNOLENCE 2 0.0000
350 FLUSHING 1 0.0000
351 HAEMOGLOBIN DECREASED 1 0.0000
352 ERYTHEMA 2 0.0000
353 HYPERTENSION 2 0.0000
354 PNEUMONIA 3 0.0000
355 CONSTIPATION 2 0.0000
356 WEIGHT INCREASED 2 0.0000
357 NAUSEA 7 0.0000
358 SEIZURE 1 0.0000
359 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
360 DRUG INEFFECTIVE 11 0.0000
361 EMOTIONAL DISTRESS 1 0.0000
362 RENAL FAILURE 1 0.0000
363 PAIN IN EXTREMITY 2 0.0000
364 BLOOD PRESSURE INCREASED 1 0.0000
365 VOMITING 3 0.0000
366 TREMOR 1 0.0000
367 DIZZINESS 3 0.0000
368 TOXICITY TO VARIOUS AGENTS 1 0.0000
369 MUSCLE SPASMS 1 0.0000
370 BLOOD GLUCOSE INCREASED 1 0.0000
371 ANAEMIA 1 0.0000
372 HYPOTENSION 1 0.0000
373 DECREASED APPETITE 1 0.0000
374 FEELING ABNORMAL 1 0.0000
375 ANXIETY 1 0.0000